Alasdair Thong
InvestorPartner at Selvedge Venture Β· Venture Partner, Healthcare at Ada Ventures
London
Writes $250K β $1M checks Β· typically $500K
About
Alasdair Thong is the founder of Selvedge Venture, focusing on deep technology applied to life sciences and healthcare. He has previously worked on the investment teams of six venture capital firms, including Index Ventures, Medicxi, Leaps (Bayer AG), Mubadala Capital Ventures, Luminous Ventures and Ada Ventures, and holds advisory roles with several startups and funds. His work centers on the convergence of technology and life sciences, particularly the use of artificial intelligence and machine learning in healthcare and life sciences.
Invests in
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Experience
- Alloy Therapeutics, Inc.CEO, Sovereign Innovation Divisioncurrent2025 β presentLondon, United Kingdom
- Alloy Therapeutics, Inc.Board Observer2025 β 2026Waltham, Massachusetts, United States
- UniTartu VenturesInvestment Committee Membercurrent2026 β presentTartu, Tartumaa, Estonia
- Multiomic HealthCo-Founder and Non-Executive Directorcurrent2021 β presentLondon, England, United Kingdom
- Ada VenturesVenture Partner: Healthcarecurrent2020 β presentLondon, England, United Kingdom
- AlcolaseNon Executive Directorcurrent2026 β presentCopenhagen
- Selvedge VentureFounding Partnercurrent2019 β presentLondon, England, United Kingdom
- PharmaCCXBoard Observercurrent2021 β presentZug, Switzerland
- Avro Life ScienceInvestor/Advisorcurrent2021 β presentWaterloo, Ontario, Canada
- Ochre BioInvestorcurrent2021 β presentOxford, England, United Kingdom
- Exogene Ltd.Investor/Advisorcurrent2021 β presentLondon and Oxford, United Kingdom
- BIOS Health LtdInvestor/Advisorcurrent2021 β presentCambridge, UK
- BIOS Health LtdBusiness and Corporate Development2020 β 2022London and Cambridge, UK
- Ollin BiosciencesBoard Observer2023 β 2026Austin, TX
- Mubadala CapitalVenture Partner2020 β 2025London, England, United Kingdom
- MetseraInvestor2023 β 2025London Area, United Kingdom
- Ellison Institute of Technology OxfordBD, Licensing, Acquisitions and Investments2024 β 2025Oxford, UK
- Tony Blair Institute for Global ChangeConsultant (Advisory)2023 β 2024London, England, United Kingdom
- KdT VenturesAdvisor2020 β 2022London, England, United Kingdom
- BayerDirector Venture Investments2017 β 2019Berlin, Germany and London, United Kingdom
Education
- University of CambridgeMaster of Philosophy (MPhil), Bioscience Enterprise
- SOAS University of LondonBA (Hons), Law and Chinese
- Beijing Normal UniversityChinese Language
- Fudan UniversityChinese Language
- Eton College
Skills & more
+7 more
Private EquityValuationContract LawDrug DevelopmentBiotechnologyPharmaceutical IndustryDue DiligenceLanguages Cantonese Β· English Β· French Β· Mandarin Β· Turkish
From Alasdair's professional profile.
Same school
Also attended University of Cambridge621
+ 615 more
Also attended SOAS University of London29
+ 23 more
Also attended Beijing Normal University13
+ 7 more
Also attended Fudan University85
+ 79 more
Shared employers
Also worked at UniTartu Ventures1
Also worked at BIOS Health Ltd2
Also worked at Ollin Biosciences1
Also worked at Tony Blair Institute for Global Change4
Colleagues at Selvedge Venture
Network2
Investors connected to Alasdair in public investor directories β a warm-intro map.

.png)

















:format(webp)/f/174198/3860x2650/640b11971a/steel-blue-chan-yip.png)











